PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic
  • Breakouts

Breakouts

West African Resources (ASX: WAF)

West African Resources (ASX: WAF): Record Production and Cash Surge

Aug 7, 2026
Proactive Equities Team

West African Resources (ASX: WAF) delivers record quarterly gold output, strong cash generation, and expanding reserves, reinforcing its position as West Africa’s leading unhedged mid‑tier gold producer with a clear path to 500 koz pas from 2027.

Fleetwood (ASX: FWD)

Fleetwood (ASX: FWD): Chart Breakout Meets a Cleaner Business Story

Jul 19, 2026
Proactive Equities Team

Fleetwood is simplifying its business through modular buildings and worker accommodation. The Red Dog Village purchase, Camec sale, and factory changes aim to improve focus, reduce complexity, and strengthen long-term earnings visibility.

Island Pharmaceuticals (ASX: ILA)

Island Pharmaceuticals (ASX: ILA) Breaks Its Downtrend as Galidesivir News Puts It Back in Play

Jul 8, 2026
Proactive Equities Team

Island Pharmaceuticals has regained market attention after breaking a long-term downtrend, supported by Galidesivir developments and strong trading momentum. Recent updates across biodefence, manufacturing, and intellectual property have improved sentiment, although confirmation above key resistance remains important

Solstice Minerals (ASX: SLS)

Solstice Minerals (ASX: SLS) Breaks Out as Nanadie Turns into a Bigger Copper- Gold Story

Jul 5, 2026
Proactive Equities Team

Solstice Minerals has gained momentum after strong drilling results at its Nanadie copper-gold project. The explorer is expanding its resource potential, backed by fresh funding, multiple exploration targets, and a bullish share price breakout supported by rising trading volume.

Avecho Biotechnology (ASX: AVE)

Avecho Biotechnology (ASX: AVE): Breakout Above Long-Term Resistance Puts Trend Sustainability in Focus

Jun 26, 2026
Proactive Equities Team

Avecho’s rally reflects Phase III CBD-insomnia progress, patent wins, and improving investor confidence. The biotech commercialises its TPM delivery platform across pharma, skincare, and animal health, while its production business supports higher-risk human health programs.

4DMedical (ASX: 4DX)

4DMedical (ASX: 4DX) Pulls Back After Breakout Rally

Jun 26, 2026
Proactive Equities Team

4DMedical slipped to A$4.57 after its breakout rally, as traders took profit near A$5.00. Momentum remains constructive, but holding A$4.25–A$4.50 is crucial while CT expansion, acquisitions and SaaS growth support the broader story.

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1234567
Page 4 of 7